Navigation Links
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Date:6/10/2009

Calvert Research, LLC (a unit of Calvert Holdings, Inc.) today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology platform and novel compounds which have the potential to treat a debilitating eye disease known as Age-related Macular Degeneration (AMD).

Cary, NC (PRWEB) June 9, 2009 -- Calvert Research, LLC (a unit of Calvert Holdings, Inc.) today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology platform and novel compounds which have the potential to treat a debilitating eye disease known as Age-related Macular Degeneration (AMD). The patented compounds and technology licensed by Calvert T1 were developed in the laboratory of Dr. David H. Coy and his team at the Peptide Research Laboratory at Tulane University.

AMD is a leading cause of blindness in the elderly, affecting millions worldwide and results from the progressive deterioration of the macula, which are the light-sensitive cells of the central retina at the back of the eye. AMD is characterized by two types: a dry (atrophic) and wet (exudative) form. Wet AMD occurs when abnormal blood vessels behind the retina begin to grow under the macula, often leaking blood and fluid that can lead to visual distortions, a decrease or loss of central vision, and eventual blindness.

The preclinical stage compounds license
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. Calvert Research and Auburn University Announce Joint Venture
2. Calvert Labs Announces the Hiring of Terry Ladd
3. Calvert Research and CureDM Sign Collaborative Agreement
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
10. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
11. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
(Date:11/24/2009)...ilable in German . , Whether it,s CD packag... (Radio Frequency Identification) are increasingly...t possible to label objects or goods and identify ...iate scanner can read and process the data contain...ods under production conditions of up to 100 degre...
(Date:11/24/2009)... The New York investment bank KTA Capital,s cli...d an AU$6.7 mil convertible note private placement...lacement was arranged by KTA Capital as Neuren,s e... New York (PRWEB) November 23, 2009 ...pital, LLC ("KTA Capital") has announced...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced that it has received notice fro...any,s common stock will be,suspended as of Novembe...e,Securities and Exchange Commission, which will r..., unless the company files an appeal to the Nasdaq...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced the approval of all of its,"fir...he District of Delaware,(the "Bankruptcy Court"). ...lief under Chapter 11 of the United States Bankrup... orders issued by the Bankruptcy Court allow the c...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...poration (NYSE: SGP ) will hold its Annual Meeti...cago at 7:30 a.m. (CDT) (8:30 a.m. EDT). On that ...le to all interested parties via the corporate Web...nual Meeting, Fred Hassan, chairman and CEO, will ...e and progress. , , The proposed combination wit...
...oration (NYSE: BSX ) today announced the schedul...ents at the 30th Annual Scientific Sessions of the... in Boston. Highlights of the week,s events inclu...T II clinical trial and the ALTITUDE Clinical Scie... insights for implantable cardioverter defibrillat...
...ll/ -- American Oriental,Bioengineering, Inc. (NYS...improving health through the development, manufact...cription and over the counter ("OTC") products in ...rst quarter ended March 31, 2009. , Financial ... increased 18.9% year over year to,$46.1 million f...
Other Biology Technology:Schering-Plough Schedules Webcast For Annual Meeting of Shareholders 2Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 2Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 3Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 4Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 5American Oriental Bioengineering Reports First Quarter 2009 Financial Results 2American Oriental Bioengineering Reports First Quarter 2009 Financial Results 3American Oriental Bioengineering Reports First Quarter 2009 Financial Results 4American Oriental Bioengineering Reports First Quarter 2009 Financial Results 5American Oriental Bioengineering Reports First Quarter 2009 Financial Results 6American Oriental Bioengineering Reports First Quarter 2009 Financial Results 7
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
(Date:11/23/2009)...hington, D.C. The community-associated strain of ...ria resistant to most common antibioticsposes a fa...is making its way into hospitals, according to a s... Diseases . , The new threat is easily picked u...aces and has increased the overall burden of MRSA ...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Sinovac Schedules 2008 Annual General Meeting 48447 1Sinovac Schedules 2008 Annual General Meeting 48447 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 1The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 2The University of Miami Miller School of Medicine the City of Miami Microsoft and Resolute Solutions Seek to Improve Care of Diabetic Populations Us 48442 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 1American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 2American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 3American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines 48437 4
...ce later this week, it will take along three kinds...etic responses and their ability to cause disease ... STS-115 space shuttle mission scheduled for launc...-- Salmonella typhimurium, Pseudomonas aeruginosa ...as potential threats to crew health. Sending these...
... System have shown for the first time that getting... cells can reverse myotonic dystrophy, the most co...t 40,000 people in the United States have myotonic... slow, progressive wasting of the muscles, irregul...ny people don,t know they have MMD until their tee...
...ins in Tanzania revealed over 160 animal species--... species--according to an article published in the...gs elevate the importance of protecting this biolo...rn Arc Mountain range from destructive activities ...gging and poaching. , "The wealth of life that,s s...
Other Biology News:Microscopic passengers to hitch ride on space shuttle 2Microscopic passengers to hitch ride on space shuttle 3Toxic molecule may cause most common type of muscular dystrophy 2First surveys of Tanzanian mountains reveal 160+ animal species, including new & endemic 2
Adipocyte Lipolysis Colorimetric Assay Kit from Zen-Bio, Inc.
Strip Cap Tool from Bio-Rad
EZ-Retriever System from BioGenex
Calcium Flux Antagonist Chip, 4-Sipper (coated) from Caliper Life Sciences
Biology Products: